Cell Source, Inc.

CLCS · OTC · SIC 2834: Pharmaceutical Preparations
75
SEC Filings
$0.8899
Close 2026-08-31

Business Summary

Cell Source, Inc. is a Nevada-based cell therapy company focused on immunotherapy. It develops proprietary immune system management technology licensed from Yeda Research & Development (Weizmann Institute). Its core Veto Cell technology enables haploidentical hematopoietic stem cell transplantation (HSCT) under mild conditioning, aiming to prevent GvHD, graft rejection, and viral infections. The company also pursues VETO CAR-T therapy, combining Veto Cell technology with allogeneic CAR-T cell therapy for blood cancer treatment.

Latest Stock Quote

CLCS 2026-08-31 $0.8899 O:$0.59895 H:$0.8899 L:$0.574 Vol:0.0M VWAP:$0.7054
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-07-22

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2024-06-242023-12-310001493152-24-024903EDGAR78K words
2023-08-082022-12-310001493152-23-027069EDGAR75K words
2022-04-152021-12-310001493152-22-010133EDGAR—
2021-04-152020-12-310001640334-21-000923EDGAR—
2020-03-302019-12-310001640334-20-000672EDGAR—
2019-04-012018-12-310001165527-19-000034EDGAR—
2018-07-252017-12-310001165527-18-000154EDGAR—
2016-04-142015-12-310001165527-16-000733EDGAR—
2015-03-132014-12-310001144204-15-015954EDGAR—
2014-03-252013-12-310001165527-14-000161EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2024-11-142024-09-300001493152-24-045964EDGAR23K words
2024-08-192024-06-300001493152-24-033055EDGAR20K words
2024-07-292024-03-310001493152-24-029448EDGAR16K words
2023-11-092023-09-300001493152-23-040079EDGAR21K words
2023-09-192023-06-300001493152-23-033011EDGAR19K words
2023-08-232023-03-310001493152-23-029915EDGAR16K words
2022-12-082022-09-300001493152-22-034876EDGAR—
2022-12-022022-06-300001493152-22-034255EDGAR—
2022-11-022022-03-310001493152-22-030233EDGAR—
2021-11-152021-09-300001493152-21-028675EDGAR—
2021-08-122021-06-300001493152-21-019491EDGAR—
2021-05-172021-03-310001493152-21-011971EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2025-06-270001641172-25-016833EDGAR1K words
2024-04-090001493152-24-014035EDGAR0K words
2022-07-210001493152-22-019997EDGAR—
2022-05-060001493152-22-012387EDGAR—
2022-03-110001493152-22-006672EDGAR—
2021-04-020001640334-21-000755EDGAR—
2019-04-190001165527-19-000053EDGAR—
2015-11-160001165527-15-000545EDGAR—
2015-11-050001165527-15-000524EDGAR—
2015-08-190001165527-15-000418EDGAR—

75 total filings indexed. 43 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

hematological-malignancies-(blood-cancers) allogeneic-hematopoietic-stem-cell-transplantation-(hsct) car-t-cell-therapy organ-transplantation non-malignant-hematological-conditions

Company Identity

CIK0001569340
TickerCLCS
ExchangeOTC
SIC2834: Pharmaceutical Preparations
IncorporatedNV
HeadquartersHouston, Texas

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 19d409aa140ee3de7dcb8939710535b412eed78d2076732e160b3ba7d400bbd4
parent: 9f301d4b67eeebd331b5c7ad13a9ed1f6786d8cd18630720110b88ddaf351f1d
content hash: 077b7b26e7f413c89bcde396c9ae4175eeb74d8c23f1b7433940ce96b7e82a64
signed: 2026-09-28T19:00:45.956Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up CLCS using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on CLCS, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/CLCS (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.